Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact

	Gene summary
	Malignant transformation analysis
	Malignant transformation related pathway analysis
	Cell-cell communication analysis
	Single-cell gene regulatory network inference analysis
	Somatic mutation of malignant transformation related genes
	Related drugs of malignant transformation related genes

Gene: SEC61A1

Gene summary for SEC61A1

Gene summary.

Gene information	Species	Human
	Gene symbol	SEC61A1
	Gene ID	29927
	Gene name	SEC61 translocon subunit alpha 1
	Gene Alias	ADTKD5
	Cytomap	3q21.3
	Gene Type	protein-coding
	GO ID	GO:0001655
	UniProtAcc	B3KME8

Top

Malignant transformation analysis

Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells

Malignant transformation involving gene list.

Entrez ID	Symbol	Replicates	Species	Organ	Tissue	Adj P-value	Log2FC	Malignancy
29927	SEC61A1	HTA11_1938_2000001011	Human	Colorectum	AD	2.14e-03	3.53e-01	-0.0811
29927	SEC61A1	HTA11_347_2000001011	Human	Colorectum	AD	2.13e-11	4.11e-01	-0.1954
29927	SEC61A1	HTA11_2112_2000001011	Human	Colorectum	SER	1.54e-04	9.01e-01	-0.2196
29927	SEC61A1	HTA11_696_2000001011	Human	Colorectum	AD	1.09e-04	3.53e-01	-0.1464
29927	SEC61A1	HTA11_1391_2000001011	Human	Colorectum	AD	1.14e-03	5.02e-01	-0.059
29927	SEC61A1	HTA11_99999965062_69753	Human	Colorectum	MSI-H	4.70e-02	1.01e+00	0.3487
29927	SEC61A1	HTA11_99999971662_82457	Human	Colorectum	MSS	1.91e-17	7.10e-01	0.3859
29927	SEC61A1	HTA11_99999974143_84620	Human	Colorectum	MSS	1.62e-03	3.32e-01	0.3005
29927	SEC61A1	A002-C-116	Human	Colorectum	FAP	1.69e-02	-1.26e-01	-0.0452
29927	SEC61A1	CRC-1-8810	Human	Colorectum	CRC	3.32e-02	1.76e-01	0.6257
29927	SEC61A1	LZE2T	Human	Esophagus	ESCC	1.15e-07	1.12e+00	0.082
29927	SEC61A1	LZE4T	Human	Esophagus	ESCC	2.81e-06	2.67e-01	0.0811
29927	SEC61A1	LZE7T	Human	Esophagus	ESCC	7.13e-15	1.22e+00	0.0667
29927	SEC61A1	LZE8T	Human	Esophagus	ESCC	2.23e-05	2.44e-01	0.067
29927	SEC61A1	LZE20T	Human	Esophagus	ESCC	4.11e-07	2.36e-01	0.0662
29927	SEC61A1	LZE22D1	Human	Esophagus	HGIN	7.63e-03	-6.72e-02	0.0595
29927	SEC61A1	LZE22T	Human	Esophagus	ESCC	5.60e-04	7.26e-01	0.068
29927	SEC61A1	LZE24T	Human	Esophagus	ESCC	2.99e-19	6.90e-01	0.0596
29927	SEC61A1	LZE21T	Human	Esophagus	ESCC	7.55e-05	-1.91e-02	0.0655
29927	SEC61A1	P1T-E	Human	Esophagus	ESCC	2.01e-12	9.37e-01	0.0875

Page: 1 2 3 4 5 6 7

Transcriptomic changes along malignancy continuum.

Tissue	Expression Dynamics	Abbreviation
Colorectum (GSE201348)		FAP: Familial adenomatous polyposis
		CRC: Colorectal cancer
Colorectum (HTA11)		AD: Adenomas
		SER: Sessile serrated lesions
		MSI-H: Microsatellite-high colorectal cancer
		MSS: Microsatellite stable colorectal cancer
Esophagus		ESCC: Esophageal squamous cell carcinoma
		HGIN: High-grade intraepithelial neoplasias
		LGIN: Low-grade intraepithelial neoplasias
Liver		HCC: Hepatocellular carcinoma
		NAFLD: Non-alcoholic fatty liver disease
Oral Cavity		EOLP: Erosive Oral lichen planus
		LP: leukoplakia
		NEOLP: Non-erosive oral lichen planus
		OSCC: Oral squamous cell carcinoma
Prostate		BPH: Benign Prostatic Hyperplasia
Skin		AK: Actinic keratosis
		cSCC: Cutaneous squamous cell carcinoma
		SCCIS:squamous cell carcinoma in situ
Thyroid		ATC: Anaplastic thyroid cancer
		HT: Hashimoto's thyroiditis
		PTC: Papillary thyroid cancer

∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer

Figure of enriched GO biological processes.

Tissue	Disease Stage	Enriched GO biological Processes
Colorectum	AD
Colorectum	SER
Colorectum	MSS
Colorectum	MSI-H
Colorectum	FAP

∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).

Page: 1 2 3 4 5 6 7 8 9

Enriched GO biological processes.

GO ID	Tissue	Disease Stage	Description	Gene Ratio	Bg Ratio	pvalue	p.adjust	Count
GO:0072594	Colorectum	AD	establishment of protein localization to organelle	148/3918	422/18723	7.95e-12	1.04e-09	148
GO:0090150	Colorectum	AD	establishment of protein localization to membrane	100/3918	260/18723	6.01e-11	6.33e-09	100
GO:0006605	Colorectum	AD	protein targeting	105/3918	314/18723	1.39e-07	6.44e-06	105
GO:0007029	Colorectum	AD	endoplasmic reticulum organization	31/3918	87/18723	1.08e-03	1.00e-02	31
GO:0070972	Colorectum	AD	protein localization to endoplasmic reticulum	26/3918	74/18723	3.28e-03	2.40e-02	26
GO:0006620	Colorectum	AD	posttranslational protein targeting to endoplasmic reticulum membrane	7/3918	12/18723	5.09e-03	3.38e-02	7
GO:0071806	Colorectum	AD	protein transmembrane transport	21/3918	59/18723	6.58e-03	4.08e-02	21
GO:00725941	Colorectum	SER	establishment of protein localization to organelle	111/2897	422/18723	4.98e-09	4.49e-07	111
GO:00901501	Colorectum	SER	establishment of protein localization to membrane	68/2897	260/18723	5.55e-06	2.01e-04	68
GO:00066051	Colorectum	SER	protein targeting	76/2897	314/18723	3.19e-05	8.47e-04	76
GO:00066201	Colorectum	SER	posttranslational protein targeting to endoplasmic reticulum membrane	6/2897	12/18723	5.42e-03	4.03e-02	6
GO:00070291	Colorectum	SER	endoplasmic reticulum organization	23/2897	87/18723	5.77e-03	4.23e-02	23
GO:00718061	Colorectum	SER	protein transmembrane transport	17/2897	59/18723	6.64e-03	4.69e-02	17
GO:00725942	Colorectum	MSS	establishment of protein localization to organelle	139/3467	422/18723	5.75e-13	1.12e-10	139
GO:00901502	Colorectum	MSS	establishment of protein localization to membrane	90/3467	260/18723	4.11e-10	3.49e-08	90
GO:00066052	Colorectum	MSS	protein targeting	97/3467	314/18723	6.76e-08	3.46e-06	97
GO:00709721	Colorectum	MSS	protein localization to endoplasmic reticulum	25/3467	74/18723	1.25e-03	1.20e-02	25
GO:00718062	Colorectum	MSS	protein transmembrane transport	20/3467	59/18723	3.53e-03	2.63e-02	20
GO:0001655	Colorectum	MSS	urogenital system development	81/3467	338/18723	6.88e-03	4.43e-02	81
GO:0065002	Colorectum	MSS	intracellular protein transmembrane transport	17/3467	51/18723	8.28e-03	4.99e-02	17

Page: 1 2 3 4 5 6 7 8 9 10 11

Enriched KEGG pathways.

Pathway ID	Tissue	Disease Stage	Description	Gene Ratio	Bg Ratio	pvalue	p.adjust	qvalue	Count
hsa0511010	Liver	Cirrhotic	Vibrio cholerae infection	29/2530	50/8465	3.19e-05	2.47e-04	1.52e-04	29
hsa0414115	Liver	Cirrhotic	Protein processing in endoplasmic reticulum	114/2530	174/8465	1.16e-22	9.67e-21	5.96e-21	114
hsa0414515	Liver	Cirrhotic	Phagosome	73/2530	152/8465	1.61e-06	1.78e-05	1.10e-05	73
hsa0511011	Liver	Cirrhotic	Vibrio cholerae infection	29/2530	50/8465	3.19e-05	2.47e-04	1.52e-04	29
hsa0414122	Liver	HCC	Protein processing in endoplasmic reticulum	146/4020	174/8465	7.34e-24	2.46e-21	1.37e-21	146
hsa0306021	Liver	HCC	Protein export	21/4020	23/8465	1.20e-05	8.53e-05	4.74e-05	21
hsa0414521	Liver	HCC	Phagosome	93/4020	152/8465	4.27e-04	1.88e-03	1.05e-03	93
hsa0511021	Liver	HCC	Vibrio cholerae infection	35/4020	50/8465	1.04e-03	3.87e-03	2.15e-03	35
hsa0414132	Liver	HCC	Protein processing in endoplasmic reticulum	146/4020	174/8465	7.34e-24	2.46e-21	1.37e-21	146
hsa0306031	Liver	HCC	Protein export	21/4020	23/8465	1.20e-05	8.53e-05	4.74e-05	21
hsa0414531	Liver	HCC	Phagosome	93/4020	152/8465	4.27e-04	1.88e-03	1.05e-03	93
hsa0511031	Liver	HCC	Vibrio cholerae infection	35/4020	50/8465	1.04e-03	3.87e-03	2.15e-03	35
hsa0414130	Oral cavity	OSCC	Protein processing in endoplasmic reticulum	143/3704	174/8465	6.82e-26	2.28e-23	1.16e-23	143
hsa0306018	Oral cavity	OSCC	Protein export	21/3704	23/8465	2.42e-06	1.27e-05	6.45e-06	21
hsa0414528	Oral cavity	OSCC	Phagosome	88/3704	152/8465	2.83e-04	9.13e-04	4.65e-04	88
hsa0511026	Oral cavity	OSCC	Vibrio cholerae infection	32/3704	50/8465	3.05e-03	7.74e-03	3.94e-03	32
hsa04141113	Oral cavity	OSCC	Protein processing in endoplasmic reticulum	143/3704	174/8465	6.82e-26	2.28e-23	1.16e-23	143
hsa0306019	Oral cavity	OSCC	Protein export	21/3704	23/8465	2.42e-06	1.27e-05	6.45e-06	21
hsa04145113	Oral cavity	OSCC	Phagosome	88/3704	152/8465	2.83e-04	9.13e-04	4.65e-04	88
hsa05110111	Oral cavity	OSCC	Vibrio cholerae infection	32/3704	50/8465	3.05e-03	7.74e-03	3.94e-03	32

Page: 1 2 3 4 5

Top

Cell-cell communication analysis

Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states

Ligand

Receptor

LRpair

Pathway

Tissue

Disease Stage

Page: 1

Top

Single-cell gene regulatory network inference analysis

Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states

Cell Type

Tissue

Disease Stage

Target Gene

RSS

Regulon Activity

∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.

Page: 1

Top

Somatic mutation of malignant transformation related genes

Annotation of somatic variants for genes involved in malignant transformation

Hugo Symbol

Variant Class

Variant Classification

dbSNP RS

HGVSc

HGVSp

HGVSp Short

SWISSPROT

BIOTYPE

SIFT

PolyPhen

Tumor Sample Barcode

Tissue

Histology

Sex

Age

Stage

Therapy Types

Drugs

Outcome

SEC61A1

SNV

Missense_Mutation

c.729N>A

p.Met243Ile

p.M243I

P61619

protein_coding

tolerated(0.2)

benign(0.003)

TCGA-A2-A0YL-01

Breast

breast invasive carcinoma

Female

<65

III/IV

Chemotherapy

cytoxan

SEC61A1

SNV

Missense_Mutation

c.584N>G

p.Ala195Gly

p.A195G

P61619

protein_coding

deleterious(0.03)

benign(0.104)

TCGA-A8-A08L-01

Breast

breast invasive carcinoma

Female

>=65

III/IV

Unknown

SEC61A1

SNV

Missense_Mutation

c.691N>T

p.Arg231Trp

p.R231W

P61619

protein_coding

deleterious(0.03)

probably_damaging(0.926)

TCGA-AC-A23H-01

Breast

breast invasive carcinoma

Female

>=65

I/II

Unknown

SEC61A1

SNV

Missense_Mutation

novel

c.1157C>T

p.Ser386Phe

p.S386F

P61619

protein_coding

deleterious(0)

probably_damaging(0.98)

TCGA-AR-A2LE-01

Breast

breast invasive carcinoma

Female

>=65

I/II

Hormone Therapy

tamoxiphen

SEC61A1

SNV

Missense_Mutation

novel

c.791N>C

p.Asp264Ala

p.D264A

P61619

protein_coding

tolerated(0.11)

benign(0.026)

TCGA-BH-A0AW-01

Breast

breast invasive carcinoma

Female

<65

I/II

Chemotherapy

carboplatin

SEC61A1

SNV

Missense_Mutation

c.1253N>T

p.Pro418Leu

p.P418L

P61619

protein_coding

deleterious(0.01)

possibly_damaging(0.869)

TCGA-D8-A140-01

Breast

breast invasive carcinoma

Female

<65

I/II

Chemotherapy

doxorubicin+cyclophosphamid

SEC61A1

insertion

Frame_Shift_Ins

novel

c.1392_1393insTGGACATGTGTTGTTTCTTTCCATGCAGGGCATC

p.Gln465TrpfsTer73

p.Q465Wfs*73

P61619

protein_coding

TCGA-B6-A0IA-01

Breast

breast invasive carcinoma

Female

<65

I/II

Unknown

SEC61A1

insertion

Nonsense_Mutation

novel

c.946_947insGAATTTGCCTGCTAATCACCATTCAGGTAATTATTATGCTAACA

p.Leu316Ter

p.L316*

P61619

protein_coding

TCGA-BH-A0BD-01

Breast

breast invasive carcinoma

Female

<65

I/II

Chemotherapy

doxorubicin

SEC61A1

SNV

Missense_Mutation

c.706N>T

p.Arg236Cys

p.R236C

P61619

protein_coding

deleterious(0)

probably_damaging(1)

TCGA-A6-2686-01

Colorectum

colon adenocarcinoma

Female

>=65

I/II

Unknown

SEC61A1

SNV

Missense_Mutation

novel

c.98N>C

p.Leu33Pro

p.L33P

P61619

protein_coding

deleterious(0)

possibly_damaging(0.861)

TCGA-AA-3947-01

Colorectum

colon adenocarcinoma

Female

<65

I/II

Unknown

Page: 1 2 3 4 5 6

Top

Related drugs of malignant transformation related genes

Identification of chemicals and drugs interact with genes involved in malignant transfromation

(DGIdb 4.0)

Entrez ID

Symbol

Category

Interaction Types

Drug Claim Name

Drug Name

PMIDs

Page: 1